Oscar(OSCR) - 2025 Q4 - Earnings Call Transcript
OscarOscar(US:OSCR)2026-02-10 14:00

Financial Data and Key Metrics Changes - Total revenue for 2025 was reported at $11.7 billion, reflecting a 28% year-over-year increase [5][15] - The SG&A expense ratio improved by approximately 160 basis points to 17.5% due to efficiency gains and disciplined expense management [5][15] - The Medical Loss Ratio (MLR) increased by 570 basis points year-over-year to 87.4% [5][15] - The loss from operations for 2025 was approximately $396 million, a change of $454 million year-over-year [15][16] - The company expects a significant improvement in earnings from operations in 2026, projecting a range of $250 million to $450 million [21][24] Business Line Data and Key Metrics Changes - Membership grew to approximately 2 million in Q4 2025, a 22% increase year-over-year [13] - The company served 3.4 million members as of February 1, 2026, with expectations to start Q2 with around 3 million paid members, a 58% increase year-over-year [8][40] - Market share increased from 17% in 2025 to 30% in 2026 [8] - New product offerings, including lifestyle plans, contributed to member retention and growth [9][10] Market Data and Key Metrics Changes - Overall market membership declined by 5% year-over-year, with expectations of further contraction as passively enrolled members exit [7][38] - The individual market is expected to stabilize, with more small business owners and gig workers entering due to affordability issues in group insurance [7] - The company anticipates a market contraction tracking toward the lower end of the original projection of 20%-30% [7] Company Strategy and Development Direction - The company aims to accelerate national Individual and Family Plans (IFP) and Individual Coverage Health Reimbursement Arrangements (ICHRA) expansion [11] - Focus on creating lifestyle products with exceptional consumer experiences and driving operational excellence through AI [11][12] - The strategic approach includes disciplined pricing and product innovation to capture profitable growth as competitors exit the market [6][9] Management's Comments on Operating Environment and Future Outlook - Management described 2025 as a reset year for the industry, with higher market morbidity impacting financial performance [6][13] - The company is positioned for strong top-line growth and margin expansion in 2026, with a focus on profitability [5][11] - Management expressed confidence in the ability to manage new membership and projected MLR improvements [30][31] Other Important Information - The company has strengthened its capital position with a $410 million convertible notes offering and a new $475 million revolving credit facility [22] - As of December 31, 2025, the company had approximately $5.5 billion in cash and investments [22] Q&A Session Summary Question: How does the company get comfort on new membership for 2026 and MLR projections? - Management indicated that they have significant data on renewing members and are leveraging third-party data for new members to project behaviors accurately [27][30] Question: Can you elaborate on the utilization trends and expectations for 2026? - Utilization was modestly higher than expected in Q4, driven by members seeking care before losing subsidies [33][34] Question: What is the expected market size post-effectuation and pricing adequacy? - The market has shrunk by 5%, with significant shifts in plan designs leading to changes in membership mix [37][38] Question: What percentage of members work with brokers versus passive renewals? - Approximately 90%-95% of members come through brokers, with some direct enrollments for specific products [55] Question: How does the company plan to achieve EBITDA profitability without enhanced subsidies? - Key levers include growth, AI efficiencies, and disciplined management of medical costs [70][72]

Oscar(OSCR) - 2025 Q4 - Earnings Call Transcript - Reportify